In our future study, we will develop animal models of middle ear cholesteatoma in which potential inhibitors of EGFR/PI3K/Akt/cyclinD1 signaling pathway might become more accessible to research. The gene discussed is EGFR; the disease is cholesteatoma of middle ear.